bioRxivSystems BiologyPreprint
Formal model of Parkinson's disease neurons unveils possible causality links in the pathophysiology of the disease
Morgane Nadal, Gabriele S. Kaminski SchierleiD, Duygu DikicioǧluiD
Abstract
Parkinsons Disease is the second most common neurodegenerative disease after Alzheimers disease. Despite extensive research, the initial cause of the disease is still unknown, although substantial advances were made in understanding of its genetics and the cognate neurophysiological mechanisms. Determining the causality relationships and the chronological steps pertaining to Parkinsons Disease is essential for the discovery of novel drug targets. We developed a systematic in silico model based on available data, which puts the possible sequence of events occurring in a neuron during disease onset into light. This is the first ever attempt, to our knowledge, to model comprehensively the primary modifications in the molecular pathways that manifest in compromised neurons from the commencement of the disease to the consequences of its progression. We showed that our proposed disease pathway was relevant for unveiling yet incomplete knowledge on calcium homeostasis in mitochondria, ROS production and -synuclein misfolding. Graphical abstract HighlightsO_LIVarying calcium concentration in aging dopaminergic neurons triggers disease onset. C_LIO_LIROS production in the mitochondria potentially causes iron accumulation. C_LIO_LIIron homeostasis dysregulation is linked to -synuclein aggregation. C_LI
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synthetic neuromelanin as a trigger of inflammation in the brain, new mouse model of Parkinson's disease
Anna Tejchman, Martyna Strzelec, … Marcin Majka·bioRxiv·Apr 28, 2023
- Parkinson's disease-related Miro1 mutation induces mitochondrial dysfunction and loss of dopaminergic neurons in vitro and in vivo
Axel Chemla, Giuseppe Arena, … Cláudia Saraiva·BrainPeer-reviewed·Feb 5, 2025
- Secondary nucleation of α-Synuclein drives Mitochondria dysfunctions and Lewy body formation in Parkinson's Disease
Emily E. Prescott, Jiapeng Wei, … Suman De·bioRxiv·Sep 17, 2025
- Alpha-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinsons disease
Fanni F. Geibl, Martin T. Henrich, … Dalton James Surmeier·Molecular NeurodegenerationPeer-reviewed·Oct 8, 2024
- LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri, Michel Brahic, … Aaron D. Gitler·Acta NeuropathologicaPeer-reviewed·Mar 29, 2019
- A Mitochondrial Inside-Out Iron-Calcium Signal Reveals Drug Targets for Parkinsons Disease
V. Bharat, A. S. Durairaj, … X. Wang·bioRxiv·Oct 30, 2022